A/Prof Surender Juneja
Honorary (Principal Fellow)
The Sir Peter MacCallum Department of Oncology
161 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
Secondary outcomes of the TROG 99.03 randomized trial of systemic therapy after involved-field radiotherapy in early-stage follicular lymphoma, including toxicity, relapse and second malignancy data
DOI: 10.1016/j.radonc.2026.1113882026
Journal article
Artefactual Heat Induced Full Blood Examination Changes in a Patient With Cold Agglutinins
DOI: 10.1111/ijlh.700202025
Journal article
Characterisation of the megakaryocyte proteome in patients with Philadelphia negative myeloproliferative neoplasms
DOI: 10.1182/blood-2025-55392025
Journal article
Marked Erythroblast Haemophagocytosis in Association With Immunotherapy for Metastatic Melanoma.
DOI: 10.1002/jha2.700692025
Journal article
Computational flow cytometry reveals a high prevalence of TRBC1-restricted CD8 T-cell subsets
DOI: 10.1080/10428194.2025.24846432025
Journal article
Rates of discordant CD20 status by flow cytometry and immunohistochemistry in B-ALL
DOI: 10.1111/bjh.199092017
Journal article
Clinicopathological features and outcomes of progression of CLL on the BCL2 inhibitor venetoclax
DOI: 10.1182/blood-2017-01-763003
RECENT SCHOLARLY WORKS
2024
Journal article
Dysregulated Complement Activation in Polycythemia Vera: A Novel Mechanism for Thrombosis in Myeloproliferative Neoplasms Uncovered By Proteomic Analysis
DOI: 10.1182/blood-2024-2066142024
Journal article
An Australian Perspective on Bone Marrow Examination as a Standard Requirement for Hematology Trainees
DOI: 10.1182/hem.v21.4.2024452024
Journal article
CD34-TdT-B-ALL masquerading as Burkitt lymphoma
DOI: 10.1002/jha2.8842023
Journal article
Randomized controlled trial of omalizumab in treatment-resistant systemic and cutaneous mastocytosis (ROAM)
DOI: 10.1016/j.jaip.2023.04.008